QT Sense uses quantum sensing to help provide diagnostics for diseases such as cancer and sepsis
Dutch quantum startup QT Sense, has raised €6M to further refine its Quantum Nuova product, which aims to improve our knowledge of diseases. The funding combines equity investment from quantum-focused VC fund QDNL Participations, plus a group of angels, with grant funding from Interreg Europe.
QT Sense was spun out from the University Medical Center Groningen (UMCG) in the Netherlands. The company emerged from the research group led by Prof. Dr. Romana Schirhagl, from research on quantum sensing technology in biomedical applications